Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study.

Journal

Targeted oncology
ISSN: 1776-260X
Titre abrégé: Target Oncol
Pays: France
ID NLM: 101270595

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 11 11 2020
medline: 11 11 2020
entrez: 10 11 2020
Statut: ppublish

Résumé

The listing of the author names and affiliations, which previously read.

Identifiants

DOI: 10.1007/s11523-020-00773-3 PMID: 33170485
pubmed: 33170485
doi: 10.1007/s11523-020-00773-3
pii: 10.1007/s11523-020-00773-3
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

801-802

Commentaires et corrections

Type : ErratumFor

Auteurs

Luca Faloppi (L)

Medical Oncology Unit, Macerata General Hospital, ASUR Marche AV3, Macerata, Italy.
Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.

Marco Puzzoni (M)

Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.

Andrea Casadei Gardini (AC)

Medical Oncology Unit, IRCSS-IRST, Meldola, Italy.

Nicola Silvestris (N)

Medical Oncology Unit, IRCCS Giovanni Paolo II Cancer Center, Bari, Italy.

Gianluca Masi (G)

Medical Oncology Unit, University of Pisa, Pisa, Italy.

Giorgia Marisi (G)

Medical Oncology Unit, IRCSS-IRST, Meldola, Italy.

Caterina Vivaldi (C)

Medical Oncology Unit, University of Pisa, Pisa, Italy.

Cosmo Damiano Gadaleta (CD)

Medical Oncology Unit, IRCCS Giovanni Paolo II Cancer Center, Bari, Italy.

Pina Ziranu (P)

Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.

Maristella Bianconi (M)

Medical Oncology Unit, San Benedetto del Tronto Hospital, ASUR Marche AV5, San Benedetto del Tronto, Italy.

Cristian Loretelli (C)

International Center for T1D, Department of Biomedical and Clinical Sciences, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi "L. Sacco", University of Milan, Milan, Italy.

Laura Demurtas (L)

Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.

Eleonora Lai (E)

Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.

Riccardo Giampieri (R)

Oncology Department, Polytechnic University of Marche, Ancona, Italy.

Eva Galizia (E)

Medical Oncology Unit, Macerata General Hospital, ASUR Marche AV3, Macerata, Italy.

Paola Ulivi (P)

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy.

Nicola Battelli (N)

Medical Oncology Unit, Macerata General Hospital, ASUR Marche AV3, Macerata, Italy.

Alfredo Falcone (A)

Medical Oncology Unit, University of Pisa, Pisa, Italy.

Stefano Cascinu (S)

Medical Oncology Unit, University of Modena, Modena, Italy.

Mario Scartozzi (M)

Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy. marioscartozzi@gmail.com.
Oncologia Medica, Azienda Ospedaliera Universitaria Cagliari, Presidio Policlinico Universitario "Duilio Casula", Km 4500 Bivio per Sestu, S.S. 554, 09042, Monserrato, CA, Italy. marioscartozzi@gmail.com.

Classifications MeSH